... roadmap that depends on India's two main suppliers -- Serum Institute and Bharat Biotech -- ramping up production and five other potential vaccines ...
News
- India says it hopes to resume vaccine exports
- Initial public offerings scheduled to debut next week
Proposed Nasdaq symbol ACXP. Business: Phase 2 biotech developing antbiotics for antibiotic-resistant pathogens. AMTD Digital - Hong Kong, China, ...
- AP Interview: India says it hopes to resume vaccine exports
But experts and critics pointed out that both Serum Institute and Bharat Biotech have struggled to boost manufacturing, and that the other potential ...
- 3 Highly Profitable Businesses With Solid Financial Conditions
... Inc (NASDAQ:CORT), a Menlo Park, California-based biotechnology developer of treatments for U.S. ... The second stock that makes the cut is XPEL Inc (NASDAQ:XPEL), a San Antonio, Texas-based manufacturer, distributor and ...
- 3 Highly Profitable Businesses With Solid Financial Conditions
... 97.70% of 261 competitors operating in the biotechnology industry, and an Altman Z-Score of 41.03. ... The second stock that makes the cut is XPEL Inc (NASDAQ:XPEL), a San Antonio, Texas-based manufacturer, distributor and ...